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ABSTRACT  
The ability to adequately interpret the mental state of another person is key to complex 
human social interaction. Recent evidence suggests that this ability, considered a hallmark of 
‘theory of mind’ (ToM), becomes impaired by inflammation. However, extant supportive 
empirical evidence is based on experiments that induce not only inflammation but also induce 
discomfort and sickness, factors that could also account for temporary social impairment. 
Hence, an experimental inflammation manipulation was applied that avoided this confound, 
isolating effects of inflammation and social interaction.  
Forty healthy male participants (mean age = 25, SD = 5 years) participated in this double-
blind placebo-controlled crossover trial. Inflammation was induced using Salmonella Typhi 
vaccination (0.025 mg; Typhim Vi, Sanofi Pasteur, UK); saline-injection was used as a control. 
About 6h30m after injection in each condition, participants completed the Reading the Mind in 
the Eyes Test (RMET), a validated test for assessing how well the mental states of others can be 
inferred through observation of the eyes region of the face. 
Vaccination induced systemic inflammation, elevating IL-6 by +419% (p < .001), without 
fever, sickness symptoms (e.g., nausea, light-headedness), or mood changes (all p’s > .21). 
Importantly, compared to placebo, vaccination significantly reduced RMET accuracy (p < .05). 
RMET stimuli selected on valence (positive, negative, neutral) provided no evidence of a 
selective impact of treatment. 
By utilizing an inflammation-induction procedure that avoided concurrent sicknesses or 
symptoms in a double-blinded design, the present study provides further support for the 
hypothesis that immune activation impairs ToM. Such impairment may provide a mechanistic 
link explaining social-cognitive deficits in psychopathologies that exhibit low-grade 
inflammation, such as major depression. 
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1. INTRODUCTION 
Human and animal studies have identified inflammation as a powerful regulator of 
social behavior (Eisenberger, Moieni, Inagaki, Muscatell, & Irwin, 2017). Initial animal studies 
identified social withdrawal as a core-feature of sickness behavior, i.e., the depression-like 
constellation of symptoms that also includes anhedonia, fatigue, and depressed mood 
(Ashwood et al., 2011; Dantzer & Kelley, 2007; Dowlati et al., 2010; Miller, Buckley, Seabolt, 
Mellor, & Kirkpatrick, 2011). Subsequent neurocognitive analyses in humans expanded this 
understanding beyond mere social withdrawal, and showed, for example, that inflammation 
induces heightened feelings of social disconnection and alters sensitivity to social threats and 
rewards (Eisenberger et al., 2010; Inagaki, Muscatell, Irwin, Cole, & Eisenberger, 2012; Moieni, 
Irwin, Jevtic, Breen, & Eisenberger, 2015; Muscatell et al., 2016; Wright, Strike, Brydon, & 
Steptoe, 2005).  
More recently, experimental human research revealed that inflammation-induction 
reduces the ability to infer the affect and mental states of other people on the basis of facial 
expressions (Moieni et al., 2015), which is considered indicative of impaired Theory of Mind 
(ToM). The concept of ToM, sometimes called mentalizing (Frith & Frith, 2006), was developed 
in the context of research on autism-spectrum disorders and refers to the ability to interpret 
someone else’s desires, beliefs, and intentions, all of which are essential to human social 
interaction (Premack & Woodruff, 1978). However, impairments of ToM more broadly 
characterize a number of mental health disorders, most notably depression (Bora & Berk, 
2016). Impaired ToM is thought to explain why depressed individuals tend to withdraw from 
social contacts, report less enjoyment in social interactions, and have fewer social contacts than 
non-depressed individuals (Hirschfeld et al., 2000), whereby mood and social interactions may 
operate in a bidirectional manner (Bora & Berk, 2016). Meta-analyses have consistently 
established that depression is associated with a state of low-grade inflammation (although 
there is marked heterogeneity between studies) (Dowlati et al., 2010; Leighton et al., 2017). 
The observation that inflammation impairs ToM might thus provide a mechanistic link 
connecting inflammation with the interpersonal difficulties that characterize depression. 
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Two studies have provided direct human experimental evidence for a link between 
inflammation and ToM (Kullmann et al., 2013; Moieni et al., 2015). Both induced acute 
inflammation through the administration of bacterial endotoxin (i.e., lipopolysaccharide, LPS) 
and assessed ToM using the Reading the Mind in the Eyes Test (RMET), a validated test for 
assessing ToM (Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001). In this test, participants 
are presented photographs showing only the eye regions of emotional facial expressions, and 
are asked to select an emotion word that best describes what the person in the photograph 
might think or feel. Although Moieni et al. (2015) reported that inflammation impaired RMET 
performance. Kullmann et al. (2013) found no such impairment, but observed an enhanced 
response to RMET images in brain regions relevant to ToM (i.e., superior temporal gyrus, 
temporo-parietal junction), which might suggest that more effort was required to produce 
impairment-free performance. While potentially important, the interpretation of the above 
data is somewhat complicated by the fact that endotoxin administration, besides inflammation, 
also provokes fever and flu-like symptoms including nausea, headache and fatigue in a dose-
dependent manner (e.g., Eisenberger et al., 2010; Kullmann et al., 2013; Lasselin et al., 2016; 
Moieni et al., 2015). Considering that physical discomfort alone may produce 
neuropsychological performance decrements (Keogh, Moore, Duggan, Payne, & Eccleston, 
2013; Smith, 2016), the above observations would benefit from further experimental validation 
using a model of inflammation that minimizes such secondary illness effects. Such alternative is 
provided by inflammation-induction through vaccination against Salmonella typhi (the causal 
agent of typhoid fever). Vaccination likewise reliably initiates an acute systemic inflammatory 
response, lasting up to 12 hours, but without generating flu-like symptoms (Brydon et al., 2009; 
Harrison et al., 2015; Lacourt et al., 2015; Paine, Ring, Bosch, Drayson, & Veldhuijzen van 
Zanten, 2013 but also Harrison et al., 2009).  
The present study tested whether inflammation would lead to a decrement in the ability 
to accurately identify mental states in others and whether interpretation of positive versus 
negative facial expressions would be equally affected. The latter consideration stems from 
previous research showing that inflammation increased sensitivity to both positive and negative 
social feedback (Muscatell et al., 2016).  
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2. METHOD 
2.1 Participants 
Forty healthy young male participants from the University of Birmingham were enrolled 
a result of recruitment via online advertisement (M age = 24.7, SD = 5.2 years). Mean body 
mass index (BMI) was 23.7 (SD = 3.2 kg/m2, 16.6-29.2 kg/m2). Individuals were excluded if they 
report a history of or suspected vaccine-related allergy, food allergy/intolerance, inflammatory, 
cardiovascular, neurological, mental health or immune-related disorders, smokers, visual 
impairments (unless corrected to normal), and those on any medication 7 days prior to the test 
days. 
Participants received research credits or were paid a minimum of £40 to reimburse 
travel and expenses. Participants could win an additional £12 depending on task performance 
during one of the cognitive tasks (reward learning task; data not reported here). The study was 
conducted according to the guidelines laid down in the Declaration of Helsinki and all 
procedures were approved by the local Research Ethics Committee of the National Health 
Service (NHS). 
 
2.2 Procedures 
Participants visited the behavioral immunology laboratory on three separate occasions: 
the first visit was intended as a familiarization session, followed by two separate test days (i.e., 
 t=‒30min    t=0                       t=5h30min                 t=8h     
   
Venipuncture 
Mood rating 
Cognitive testing 
Figure 1. Study timeline. Participants were tested on two occasions, separated by a 7-day 
wash out, using an identical protocol. Cognitive testing was performed between 5.5h and 8h 
after application of vaccine or placebo (t=0). Before participation, participants visited the 
laboratory for a single 70 minutes familiarization session. 
Venipuncture 
Mood rating 
Venipuncture 
Mood rating 
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vaccination or control) planned at least one week apart. During the familiarization session, 
which took about 70 minutes, written informed consent was obtained, inclusion and exclusion 
criteria were verified, an initial set of questionnaires were completed, and participants 
performed abbreviated versions of the computer tasks for the purpose of familiarization. Figure 
1 presents the time line of the subsequent experimental sessions. On each of the two the test 
days, participants arrived at the laboratory between 8:00 and 9:00 am after an overnight fast. 
Participants were instructed to refrain from strenuous physical activity and alcohol intake for at 
least 24 hours, and were asked to avoid high fat and high sugar products for at least 12 hours 
prior to the test days. Before vaccination or placebo, participants verified absence of acute 
illness, and mood and sickness symptoms were assessed (as described below), and tympanic 
body temperature was measured. Subsequently the first blood sample was taken. After 
vaccination/placebo, participants received a standardized breakfast (granola with skimmed 
milk, approx. 430 kcal), and after a 5-hour break participants again received a standardized 
meal consisting of cheese sandwiches (approx. 328 kcal). For a subset of participants, EEG data 
was also collected from about 5.5 hours to 6.5 hours post-injection (N = 20, not reported here); 
and these participants arrived back at the laboratory 1 hour earlier to allow EEG preparations. 
During the 5-hour break participants were instructed to refrain from eating, drinking (except for 
water and the meals provided), or strenuous physical activity. Fifteen minutes post-lunch a 
second blood sample was taken and tympanic body temperature was measured; then, a set of 
cognitive tests that included the computerized RMET were started. Other tasks, not reported 
here, included measures of memory, attention, learning and response inhibition. Mood was 
also assessed at several intervals during the test day; before injection and 5h30m and 8 hours 
post-injection. The final blood sample was taken about 8 hours post-injection. Test timings 
were identical across visits, as were the procedures, except for the type of injection (vaccine or 
saline-placebo) 
 
2.3 Randomization 
Participants were randomly assigned to receive vaccine or placebo (control) on the first 
day of formal testing. Randomization was performed by supporting staff who had no contact 
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with the study participants. Both participants and researchers were blind to condition order, 
and only the nurse administering the injections was aware of the order whereby a sealed 
envelope containing information about the condition was handed to the nurse before 
administering the injection. The nurse followed identical procedures for placebo and vaccine 
injection ensuring participant’s blindness to the condition. The researchers where not present 
when the injection was administered. 
 
3. MATERIALS 
3.1 Reading the Mind in the Eyes test (RMET) 
The RMET is considered a test of theory of mind, a cognitive process sometimes referred 
to as “mind-reading” and “social intelligence” (Baron-Cohen et al., 2001). The RMET was 
developed to measure social sensitivity in typical adults with normal intelligence (Baron-Cohen 
et al., 2001).  
 
Stimuli  
A gray-scale digital image (subtending 9 x° X 3.6 y° of visual angle) of the eye region of a 
face (including eyes and eyebrows) was presented in the middle of a grey field on a computer 
monitor. Four words describing mental states accompanied each test stimulus, presented in 
black Arial font (subtending 2.6 x° X 0.7 x° of visual angle).  
 
Procedure  
The test display comprised a test eye image and four words placed in the centre of the 
screen. The participant was instructed to select the word that best described what the person 
in the test image was thinking or feeling by pressing one of four computer keys (Q, P, A, L) that 
spatially corresponded to the position of each word. The correct (target) word had the same 
emotional valence as the accompanying three foil words. For example, the target word, 
‘panicked’, was accompanied by ’arrogant’, ‘jealous’ and ‘hateful’. Target words were equally 
likely to appear in one of the four word locations on the screen. Each test display remained 
visible until a key response was made; the next test display was immediately presented 
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thereafter. One block comprised of 18 test displays was completed on each day, with a 
different set of 18 test displays used on the second test day; the order of the display sets used 
was counterbalanced across participants. The two sets were comparable with regards to the 
sex of the faces (50% female) and number of items depicting positive, neutral and negative 
emotional expressions (fully crossed with sex, making three test displays for each sex X 
expression condition within each block). In line with previous studies, a glossary containing a 
definition of each word was available to the participant. Accuracy and response time were 
calculated as the percentage of correct responses and time to complete the task, respectively. 
Additional accuracy scores were calculated to assess the effect of emotional valence of the 
mental state discrimination (positive, neutral, negative expressions; see Maurage et al. 2011). 
 
3.2 Typhoid vaccination 
Participants received 0.5 mL Salmonella typhi capsular polysaccharide vaccine (0.025 mg 
in 0.5 mL, Typhim Vi, Sanofi Pasteur, UK) and a saline placebo (0.5 mL) via intra-muscular 
injection in the deltoid muscle of the non-dominant arm by a certified nurse. Typhoid vaccine 
was selected as a low-grade inflammatory stimulus, since this vaccine is known to induce 
increases in circulating pro-inflammatory cytokine levels with no significant effect on body 
temperature (Paine et al., 2013). 
 
3.3  Mood and sickness symptoms 
Current mood and presence of sickness symptoms was assessed using a modified 
version of the Profile of Mood States – Short Form (POMS-SF; Curran, Andrykowski, and Studts 
1995). The POMS-SF consists of 32 items asking ‘How are you feeling right now:’ followed by 
the item. Items were rated on a five-point Likert scale (0 = not at all, 1 = a little, 2 = moderately, 
3 = quite a bit, to 4 = extremely). Scores for POMS subscales (tension-anxiety, anger-hostility, 
fatigue-inertia, vigour-activity, confusion-bewilderment, depression-dejection) were computed 
by summing ratings on individual items. Six items were added to assess physical sickness (light-
headed, nausea, faint, disgusted) and behavioral sickness (withdrawn, sociable). 
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3.4 Blood sampling 
Blood was collected into one 6 ml vacutainer containing ethylenediaminetetraacetic 
acid (EDTA) as anticoagulant (Becton Dickinson Diagnostics, Oxford, United Kingdom). Samples 
were immediately centrifuged at 1500g for 10 min at 4 °C and plasma was aliquoted and stored 
at -80 °C for later cytokine assessment of plasma interleukin-6 (IL-6). Plasma IL-6 was measured 
in duplicate using high-sensitivity enzyme-linked immunosorbent assay (ELISA) (Quantikine HS 
Human IL-6 ELISA, R&D Systems, UK) in accordance with the manufacturer’s instructions. The 
limits of detection of this assay was .11 pg/mL, with an intra-assay coefficient of variation (CVs) 
of 4.2%. All samples from the same participants were assayed in the same run. 
 
3.5 Anthropomorphic Measures 
Participants were asked to remove footwear and coats and empty their pockets before a 
body composition measurement was taken using a TANITA BC-545N body composition analyser 
(Tanita Europe, Amsterdam, The Netherlands), a device that uses bioelectrical impedance 
analysis. A stadiometer was used to measure height. 
 
4. STATISTICAL ANALYSIS 
All data were analyzed using SPSS v.24.0 (IBM-SPSS Inc., Chicago, IL, USA). Individuals 
with accuracy scores > 2.5 SD from the mean were excluded from analysis (N = 1). ANOVAs 
were performed to compare treatment (placebo vs vaccine). For POMS subscales, linear mixed 
models were used. Model simplicity and likelihood ratio tests were used to select appropriate 
covariance structures. Treatment and time were fixed and repeated factors; subject was 
entered as a random factor; and baseline scores were entered as a time-varying covariate. The 
effects of interest were interactions between time and treatment and main effects of 
treatment. Tests of simple main effects were performed on the linearly independent pairwise 
comparisons between the estimated marginal means for all analyses. 
For IL-6 analyses, log10 transformation was applied because of the skewed distribution 
of raw IL-6 values. Three participants were excluded because of high baseline values indicative 
of a possible infection. Injection order (p = .21) and stimulus set order (p = .80) were added as 
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between-subjects factors but showed no effect in any of the analyses and were therefore 
omitted from the final analyses. To correct for mood and sickness (POMS), difference scores 
were calculated for each subscale for the vaccine condition from baseline to peak IL-6 level 
(either 5h30m or 8h post-injection) and added as covariate if of interest. Correlational analysis 
with IL-6 was conducted on the peak IL-6 difference scores during the vaccine condition. 
 
5. RESULTS 
5.1 Responses to Typhoid vaccination 
5.1.1 Physiological responses 
As shown in Table 1, after typhoid vaccination, participants showed a significantly 
greater increase in plasma IL-6 at 5h30m (+348%, mean difference 4.1, SE = 0.3) as compared to 
placebo (-14%, mean difference -0.1, SE = 0.0), t(32) = -15.14, p < .001. IL-6 remained elevated 
until at least 8 hours post injection (+227%, mean difference = 2.7, SE = 0.2), t(33) = -15.41, p = 
<.001; treatment (placebo, vaccine) x time (0h, 5h30, 8h) interaction, F(2, 50) = 58.04, p < .001, 
ηp
2
 = .84). The peak IL-6 response occurred at 5h30m post-injection for most participants 
(average peak increase was 419%). Core body temperature showed no effect of treatment, F(2, 
54) = 1.32, p = .28, ηp
2
 = .05). 
 
 0 hours 5h30m 8 hours 
Placebo 1.11 (0.58) 0.95 (0.65) 0.97 (0.69) 
Vaccine 1.18 (0.62) 5.29 (1.72) 3.86 (1.26) 
 
Table 1. Mean (SD) IL-6 in pg/mL for the placebo and vaccine condition. Column labels 
represent time since vaccination 
 
5.1.2 Affective responses, physical symptoms, and expectancy 
No significant time by condition interactions were evident for any of the POMS 
subscales or total mood score (all F’s < 1). POMS data are summarized in Table 2. Results also 
indicated that participants were blind to their condition at the first visit: on test day 1, 55.6% of 
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the participants reported the condition correctly at the end of the test day, which is at chance 
level, χ2(1) = .44, p = .51. At the end of test day 2, 83.8% correctly guessed the condition they 
were in, χ2(1) = 16.89, p < .001. To rule out partial expectancy effects, sensitivity analyses were 
run including only test day 1 (using between-subject comparisons), which yielded essentially 
identical results (results presented below). 
 
 
 0 hours 5h30m 8 hours 
 Placebo Vaccine Placebo Vaccine Placebo Vaccine 
Anger 1.6 (2.2) 1.3 (2.1) 0.7 (1.4) 1 (2.4) 1.4 (2.6) 1.4 (2.1) 
Confusion 4 (2.3) 3.5 (2.3) 3.2 (2.2) 3.4 (2.0) 4.5 (2.2) 4.3 (2.2) 
Depression 1.3 (2) 1.3 (2.2) 0.6 (1.2) 0.8 (1.9) 1 (2.1) 1.4 (2.3) 
Fatigue 3.9 (4.1) 3.8 (3.8) 2.8 (4.7) 3 (4.5) 5.3 (3.7) 6 (3.9) 
Tension 1.6 (2.2) 1.2 (1.1) 1 (1.9) 1.5 (2.2) 1.7 (2.9) 1.3 (2) 
Vigour 7.2 (4.2) 7.3 (3.3) 7.0 (3.6) 7.2 (3.4) 4.7 (3.7) 4.3 (3.3) 
Behavioral Sickness 2.5 (1.5) 2.2 (1.3) 2.3 (1.3) 2.1 (1.3) 2.6 (1.3) 2.4 (1.3) 
Physical Sickness 0.8 (1.6) 0.8 (1.2) 0.8 (1.9) 0.8 (1.4) 1.1 (1.8) 0.8 (1.3) 
 
Table 2. Mean POMS subscales (SD) (mood and physical and behavioral symptoms) separated 
by condition. No interaction effects between treatment and time were evident (all F’s < 1). 
Column labels represent time since vaccination. 
 
5.2 Reading the eyes in the mind test 
As can be seen in Figure 1a, vaccination (vs. placebo) led to a significant decrease in 
performance on the RMET, F(1, 38) = 4.78, p = .035, ηp
2
 = .11. These results remained significant 
after adjusting for mood, behavioral or physical symptoms as well as for vaccination order. 
Sensitivity analyses including only test day 1 (using a between-group comparison), yielded 
virtually identical results, F(1, 37) = 9.08, p = .005, ηp
2
 = .20). Similar responses times were 
observed for vaccine (M = 8.1 sec, SD = 4.4 sec) and placebo (M = 8.2 sec, SD = 4.5 sec), F(1, 38) 
  
12 
 
= .03, p = .867, ηp
2
 = .00. Separate analyses of RMET stimuli selected on valence (positive, 
negative, neutral) provided no evidence of a selective impact of treatment (see Figure 1b), F(2, 
76) = .08, p = .921, ηp
2
 = .00. Finally, the decreased RMET performance was not correlated with 
changes in IL-6 in the vaccine condition, r(36) = .16, p = .367.  
   
6. DISCUSSION 
The present study tested whether inflammation impairs the ability to infer other’s 
mental states and affect, which is considered a key aspect of Theory of Mind (Frith & Happe, 
1999). Inflammation, as measured by IL-6, was effectively induced using a typhoid vaccination 
without causing sickness symptoms (e.g., fever, light-headedness, nausea, faint, withdrawn) or 
deterioration of mood. Moreover, analyses indicated that participants were blind to their 
condition at the first visit, which largely excluded confounding by expectancy effects. In line 
with the hypothesis, vaccine resulted in poorer performance on the RMET compared to the 
placebo condition. The current findings provide further experimental support to the idea that 
inflammation may drive social-cognitive deficits in psychopathologies that exhibit enhanced 
A B 
Figure 2. Mean accuracy scores for RMET total score (A), and for each emotional valence (B) 
for the placebo and vaccine condition. Errors bars indicated SEM. Please note that the y-axes 
start at 50% accuracy. 
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inflammation, such as major depression (Dantzer, O’Connor, Freund, Johnson, & Kelley, 2008; 
Eisenberger et al., 2017).  
A possible alternative interpretation of the current results is that the lower performance 
during inflammation reflects reduced motivation. Motivational changes, which are considered a 
characteristic effect of inflammation, could thus account for the decreased RMET performance 
(e.g., Draper et al., 2017; Harrison et al., 2015; Lasselin et al., 2016). If this were the case, 
participants should have performed more poorly and taken less time to carefully inspect the 
stimuli. However, the results did not seem consistent with this interpretation; the time 
participants took to complete the task was identical across conditions while performance 
accuracy was not. Although the current study was not specifically designed to assess social-
related motivational changes, the observed pattern of results would not seem consistent with 
weakened motivation explaining the RMET performance deficits shown here.  
The results further suggested that the inflammatory stimulus applied in the current 
study impaired ToM skills independent of emotional valence. I.e., the ability to infer positive 
mental states was affected to a similar degree as inferences on negative and neutral mental 
states. This observation is consisted with that of Muscatell et al. (2016), who showed that 
endotoxin-induced inflammation enhanced neural responsivity in threat-related (e.g., bilateral 
amygdala) and reward-related (e.g., ventral striatum) brain regions, as well as in a region 
involved in inferring mental states of others (dorsomedial prefrontal cortex (DMPFC)) to the 
same degree for negative versus positive social feedback. Muscatell et al. (2016) and Kullmann 
et al. (2013) further showed endotoxin-induced heightened neural sensitivity in the core region 
implicated in mentalizing. The fact that Kullmann et al. (2013) failed to find a behavioral effect, 
may perhaps be taken to suggest that individuals with inflammation may find the RMET task 
harder and so require more brain resources to achieve the same level of performance.  
Clinically, although still somewhat speculatively at this point, the current findings 
suggest that individuals with inflammation find social interactions more complex, which could 
possibly contribute to social withdrawal and further amplification of depressive symptoms 
(Cacioppo, Hughes, Waite, Hawkley, & Thisted, 2006; Heinrich & Gullone, 2006). Likewise, 
impairments in social emotion recognition may hinder optimal support seeking, whereby 
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patients might be less in tune with their social environment, e.g., less sensitive in picking up 
social cues that would otherwise guide symptom reporting and help-seeking behavior. The 
inflammatory component of depressive disorders may similarly contribute to social 
impairments and withdrawal that characterize these disorders (Miller & Raison, 2016). 
A notable feature of the current study is that the typhoid vaccination used here elicited a 
smaller inflammatory response, raising IL-6 levels 4-fold, compared to the endotoxin 
manipulations used previously, which raised IL-6 levels between approximately 100-fold with a 
lower endotoxin dose (0.4 ng/kg body weight) up to roughly 1000-fold with a high dose (2 ng/kg 
body weight) (Draper et al., 2017; Eisenberger, Inagaki, Rameson, Mashal, & Irwin, 2009; 
Grigoleit et al., 2011; Kullmann et al., 2013; Lasselin et al., 2016; Moieni et al., 2015; Muscatell 
et al., 2016). Although it could be argued that the modest elevation of IL-6 observed here 
simply reflects diurnal variation (Agorastos et al., 2014; Nilsonne, Lekander, Åkerstedt, 
Axelsson, & Ingre, 2016), this account is unlikely as IL-6 changes were specific to the vaccine 
condition and not found in the placebo condition, even though measurements were obtained 
at the same time of the day in both conditions. Producing subtle increases inflammation can be 
considered an advantage for research aimed at uncovering cognitive consequences of 
inflammation. For example, in terms of generalizability, the level of immune activation seen 
here is more akin to the low-grade inflammatory levels seen in depressed individuals, as well as 
medical conditions such as diabetes and atherosclerosis that have been linked to increased 
depression risk. Moreover, as argued earlier, the manipulation minimizes potentially 
confounding side effects such as sickness symptoms or significant mood deterioration (e.g., 
Dowlati et al., 2010; Maes et al., 1995; O’Brien, Scully, Fitzgerald, Scott, & Dinan, 2007). 
Typhoid vaccination is used to induce inflammation and subsequent neuropsychological effects 
subsumed under sickness behaviour, but typically without physical malaise that more typically 
denotes sickness (e.g., fever, nausea). This similarly applies to other human data in which low-
grade elevated inflammatory activity is present without overt sickness (e.g., such as in 
depression), but still showing neuropsychological phenomena like fatigue, anhedonia and 
motor slowing (e.g., Goldsmith et al., 2016; Treadway, Bossaller, Shelton, & Zald, 2012). Hence, 
there seems reasonable ground to further discuss whether the term sickness behaviour 
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remains appropriate or whether we should consider new terminology (e.g., inflammation-
associated cognitive changes. Some studies using typhoid vaccination have reported modest 
elevations in fatigue after vaccination, although this has not been uniformly observed (Brydon 
et al., 2008; Harrison et al., 2015; Harrison et al., 2009; but also Paine et al., 2013). Inspection of 
the data suggests that studies which measured fatigue 2-4 hours post vaccination observed 
elevated fatigue, whereas those using later time-points did not. However, further studies are 
needed to establish if timing is indeed a factor. The performance decrement of 5.6% on the 
RMET we observed in the current study is comparable to the study of Moieni et al. (2015) 
(about -5%). Interestingly, such differences are also observed in individuals with major 
depression as compared to controls (Kettle, O’Brien-Simpson, & Allen, 2008; Lee, Harkness, 
Sabbagh, & Jacobson, 2005; Szanto et al., 2012). However, perhaps the more significant point 
to be taken from these data goes beyond the exact magnitude of the observed effects, but is 
the experimental demonstration that mild inflammation affects social cognition. A further 
strength of the study is the relatively large sample size, which is the largest typhoid vaccination 
study to date, although it remains possible that some more subtle effects may have been 
missed: i.e., analyses established that at a power of .80, and assuming an alpha of .05, the 
current samples size was sufficient to detect small to moderate effect sizes. Limitations are that 
the current model induces an acute inflammatory state, and generalization to chronic 
inflammation remains to be determined and only healthy young males were assessed. Even 
though Moieni et al. (2015) reported no sex differences in acute inflammation or its consequent 
cognitive effects, further studies are clearly needed to confirm the generalizability of the 
current effects to females and to younger and older individuals. Indeed, inflammation is a 
hallmark of ageing and replication of results to such a relevant group is advised. Moreover, 
even though Lacourt et al., (2015) showed that vaccination does not affect pain tolerance or 
pain threshold and no side effects were reported in the current study, pain could have 
influenced performance and lack of assessing pain is a limitation of the study. Similarly, even 
though modified versions of the Profile of Mood Scales-Short Form (POMS-SF) have been used 
extensively in typhoid vaccination studies (e.g., Brydon et al., 2009; Harrison et al., 2015), the 
use of a modified POMS-SF to measure mood and sickness can be considered as a limitation of 
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the current study. Finally, similar to the study of Moieni et al. (2015), we found that the 
magnitude of the vaccine-induced inflammatory response was not related to behavioral 
performance. They speculated that the RMET might not be sensitive enough to capture 
incremental changes in inflammation. However, the current study showed that also a modest 
inflammatory stimulus impairs RMET performance. An alternative explanation might be that IL-
6 is not a causal factor, and perhaps more proximal inflammatory biomarkers could be explored 
(Leighton et al., 2017). 
In summary, typhoid vaccination elicited a transient low-grade inflammatory response 
in healthy young men and decreased performance on the Reading the Mind in the Eyes Test, 
tested in a double-blinded placebo-controlled crossover design. Hereby the current study 
provided direct empirical evidence for a link between heightened inflammation and lower 
ability to infer mental states of others. This finding, together with related recent reports, 
warrants a more comprehensive program of research linking inflammation and social cognition.  
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Highlights 
1. Typhoid vaccination elicited a transient low-grade inflammatory response without 
physical sickness or mood changes. 
2. Inflammation resulted in lower ability to interpret the mental state of someone else, 
suggestive of transient impairment of Theory of Mind. 
3. Inflammation may be a contributing factor to social-cognitive deficits in 
psychopathologies that exhibit enhanced inflammation, such as major depression. 
 
 
